Relationship between psoriasis severity degree and TNF-α levels in patients with psoriasis in combination with arterial hypertension
DOI:
https://doi.org/10.14739/2310-1210.2015.3.44479Keywords:
Psoriasis, Essential Hypertension, TNF-αAbstract
The urgency of the problem is determined by the frequency of comorbidity of psoriasis by essential hypertension.
Aim. In order to study the level of TNF-α in patients with psoriasis in combination with essential hypertension 102 patients were examined.
Methods and results. The main group (I group) consisted of 27 patients with psoriasis in combination with essential hypertension. There were two groups of comparisons: 26 patients with psoriasis (II group) and 49 patients with essential hypertension (III group). Severity of the disease was assessed with Psoriasis Area and Severity Index (PASI). Patients completed questionnaire The Dermatology Life Quality Index (DLQI) to study the quality of life. Determination of TNF-α in the serum were provided by indirect ELISA. It was found that patients from the 1st group more frequently had widespread forms of dermatosis, with frequent relapses, psoriatic arthropathy.
Conclusion. Cytokine activation correlated with worsening of the life quality. Regressive analysis revealed association between psoriasis severity and TNF-α serum level in patients from the main group.
References
Soloshenko, E. N. (2008). Psoriaz: e`tiopatogenez, strategiya terapii s uchetom stadii i tyazhesti processa [Psoriasis: etiopathogenesis, treatment strategy, taking into account the stage and severity of the process]. Mezhdunarodnyj medicinskij zhurnal, 3, 91–95. [in Ukrainian].
Bodnya, K. I. & Kadelnik, L. O. (2013). Suchasnyi stan problemy khronichnykh dermatoziv [Suchasnyj camp problemi hronіchnih dermatozіv]. Bukovynskyi medychnyi visnyk, 3(2), 94–99. [in Ukrainian].
Soloshenko, E`. N., Zhukova, N. V., Yarmak, T. P. & Shevchenko, Z. M. (2012). Faktor nekroza opukholi, interlejkiny i lipidnyj obmen v raznykh stadiyakh techeniya psoriaza [Tumor necrosis factor, interleukins and lipid metabolism in different stages of the flow of psoriasis]. Zdorov'e Ukrainy, 1–2, 62–64. [in Ukrainian].
Katunina, O. R. & Rezaikina, A. V. (2011). Provospalitel'nye citokiny IL-1 i FNO-α v ochagakh porazhennoj kozhi bol'nykh psoriazom [Pro-inflammatory IL-1 and TNF alpha cytokines in affected skin foci in psoriatic patients]. Vestnik dermatologii i venerologii, 4, 25–30. [in Russian].
Nestle, F. O., Kaplan, D. H. & Barker J. (2009). Psoriasis. N Engl J Med, 361(5), 496–509.
Nograles, K. E., Davidovici, B. & Krueger, J. G. (2010). New insights in immunologic basis of psoriasis. Semin Cutan Med Surg, 29(1), 3–9. doi: 10.1016/j.sder.2010.03.001.
Kalliolias, G. D., Gordon, R. A., & Ivashkiv, L. B. (2010) Suppression of TNF-alpha and IL-1 signaling identifies a mechanism of homeostatic regulation of macrophages by IL-27. J Immunol, 185, 7047–7056. doi: 10.4049/jimmunol.1001290.
Downloads
How to Cite
Issue
Section
License
Authors who publish with this journal agree to the following terms:- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access)
